News | ECG | July 20, 2017

More Than 20 Percent of Low-Risk Patients Receive Annual ECG

New study notes five times greater likelihood of downstream testing and costs for relatively healthy group of patients

More Than 20 Percent of Low-Risk Patients Receive Annual ECG

July 20, 2017 — More than one in five Ontario patients receive an electrocardiogram (ECG) during their annual health exam despite being at low risk for heart disease, according to a new study from the Institute for Clinical Evaluative Sciences (ICES).

An ECG is a common test used to record the electrical signals of the heart; the results of an ECG can provide information about the structure and function of the heart.

“An ECG is a valuable test that can save a patient’s life if they are experiencing chest pains or are at high risk of heart disease, but there is little value when patients are at low risk of cardiovascular disease and this certainly should not be a routine test as part of an annual physical exam,” said Sacha Bhatia, M.D., a scientist at ICES, cardiologist and director at Women’s College Hospital Institute for Health System Solutions and Virtual Care (WIHV).

The study, published in JAMA Internal Medicine, shows that low-risk patients who had an ECG were five times more likely to receive another diagnostic test like a stress test, echocardiogram or a cardiology consultation than those who did not have an ECG.

“Our findings show that ECGs conducted on patients as part of an annual health exam are common, and the downstream effect is an increased risk for subsequent cardiology testing and consultation cascade, even though the overall cardiac event rate in this group was very low,” added Bhatia.

The Choosing Wisely campaign, launched in 2012, recommends against non-invasive cardiac testing in low-risk and asymptomatic patients. ECGs are in their “top five” lists of low-value tests, treatments and procedures that physicians and patients should question.

The study of 3,629,859 adult patients who had at least one annual health exam between fiscal years 2010/2011 and 2014/2015 in Ontario found:

  • ECGs ordered in low-risk patients as part of the annual health exam are common, occurring in 21 percent of patients;
  • There is wide variation in physician ordering, with more than 7 percent of family physicians ordering ECGs in more than 50 percent of their low-risk patients;
  • In low-risk patients who had an ECG, they were five times more likely to receive another test (like a stress test, echocardiogram) or cardiology consultation than those who did not; and
  • Patients that did or did not receive an ECG had a very low risk of death, hospitalizations or revascularization (<0.5 per cent) at the one-year mark.

“Our findings suggest that even low-cost procedures like ECGs in low-risk patients, occur with significant frequency, and importantly can lead to more advanced testing that ends up costing the health system more with little potential benefit to patients,” said Bhatia.

For more information:

Related Content

HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG| August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging| August 18, 2017
August 18, 2017 — The American Society of...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Overlay Init